The board of directors of China Resources Phoenix Healthcare Holdings Company Limited announced the changes of the composition of the Board that with effect from August 7, 2018: Mr. Wang Yin resigned as the non-executive Director and chairman of the Company; Mr. Wu Ting Yuk, Anthony is appointed as an independent non-executive Director and chairman of the company; Mr. Song Qing is appointed as an executive Director and vice chairman of the company; Mr. Cheng Libing, an executive Director, is re-designated as the chief executive officer of the company; and Mr. Han Yuewei, an executive Director, resigned as the chief executive officer of the company and is appointed as the general manager of China Resources Healthcare Group Limited, the controlling shareholder of the company. Mr. Wu Ting Yuk, Anthony is a leader in the healthcare industry and has extensive management experience in medical system. Mr. Wu jointed the Hong Kong Hospital Authority in 1999 and was formerly its chairman from 2004 to 2013.

Mr. Wu also served as the chairman of the Chamber Council of the Hong Kong General Chamber of Commerce from 2010 to 2012, and is currently a member of its consultation committee. Mr. Wu was a partner of Ernst & Young from 1985 to 2015, and served as chairman of the EY's Far East Region from 2000 to 2005. He is also the chief advisor to MUFG Bank Ltd., the chairman of The China Oxford Scholarship Fund, an honorary professor of the Faculty of Medicine of the Chinese University of Hong Kong and the Peking Union Medical College Hospital, and an honorary fellow of the Hong Kong College of Community Medicine.

Mr. Wu is an independent non-executive director of Power Assets Holdings Limited, Guangdong Investment Limited and China Taiping Insurance Holdings Company Limited, and an executive director of Sincere Watch (Hong Kong) Limited. He was also an independent non-executive director of Agricultural Bank of China Limited from 2009 to 2015. He was also a director of the Fidelity Funds from 2011 to 2014.

Mr. Song Qing has extensive experiences in corporate management, and has over 30 years of experience and sophisticated background in the pharmaceutical industry. Mr. Song was the director of China Resources Pharmaceutical Group Limited from May 2016 to August 2018, and also its president from June 2017 to August 2018. Mr. Song is the director of China Resources Sanjiu Medical & Pharmaceutical Co Ltd.